For the Inventor, By the Inventor

Enter assignee name

Marlborough, MA, United States of America

Sunovion Pharmaceuticals Inc.

USPTO Granted Patents = 130

CIPO Patents = 15

EPO Patents = 41

Trademarks = 19

Forward Citations = 370

Loading Chart...

Loading Chart...

119 inventors (with patents filed for the assignee):

Liming Shao (21 out of 38 patents)

Michael Charles Hewitt (21 out of 33 patents)

John Emmerson Campbell (20 out of 40 patents)

4. Harold Scott Wilkinson (17 out of 20 patents)

5. H Scott Wilkinson (17 out of 18 patents)

6. Kerry Leigh Spear (16 out of 29 patents)

7. Una Campbell (15 out of 15 patents)

8. Taleen G Hanania (14 out of 15 patents)

9. Philip Glyn Jones (14 out of 16 patents)

10. Larry Wendell Hardy (14 out of 14 patents)

11. Scott C Malcolm (14 out of 15 patents)

12. John R Snoonian (13 out of 25 patents)

13. Linghong Xie (12 out of 13 patents)

14. Qun Kevin Fang (12 out of 37 patents)

15. Michele L R Heffernan (12 out of 23 patents)

Core Competencies:

Nonracemic Mixtures

Modified Release Formulations

Crystal Forms

Neurological Disorders

Psychiatric Disorders

Sublingual Films

CNS Disorders

PDE-10 Inhibitors

Metabotrophic Glutamate Receptor 5

Heteroaryl Compounds

Apomorphine Administration

Triple Reuptake Inhibitors

130 patents: Sort by Forward Citations

1. 12161758 - Modified release formulations and uses thereof (2024-12-10),

2. 12161623 - Nonracemic mixtures and uses thereof (2024-12-10),

3. 11767293 - Crystal forms and production methods thereof (2023-09-26),

4. 11738002 - Methods of treating neurological and psychiatric disorders (2023-08-29),

5. 11654113 - Modified release formulations and uses thereof (2023-05-23),

6. 11517558 - Nonracemic mixtures and uses thereof (2022-12-06),

7. 11491133 - Heteroaryl-isochroman compounds and uses thereof (2022-11-08),

8. 11440921 - Salts, crystal forms, and production methods thereof (2022-09-13),

9. 11419769 - Sublingual films (2022-08-23),

10. 11406786 - Nebulizer monitoring device, system and method (2022-08-09),

11. 11370753 - Crystal forms and production methods thereof (2022-06-28),

12. 11332462 - Heteroaryl compounds and methods of use thereof (2022-05-17),

13. 11312554 - Easy-open peel pouch (2022-04-26),

14. 11192885 - 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders (2021-12-07),

15. 11186564 - Dual NAV1.2/5HT2a inhibitors for treating CNS disorders (2021-11-30),

Sunovion Pharmaceuticals Inc. is a global biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for patients with serious medical conditions. With a commitment to scientific excellence and the goal of improving the lives of patients globally, Sunovion develops and markets a range of pharmaceutical products across several therapeutic areas, including respiratory, psychiatric, and neurological disorders. Through ongoing research and collaborations, Sunovion continues to advance its diverse pipeline of potential treatments, aiming to address unmet medical needs and make a positive impact on patient care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

130 Patents

#8 in Marlborough, MA

#155 in Massachusetts

#2,855 in US

#5,994 in the World

Marlborough, MA, United States of America

Sunovion Pharmaceuticals Inc.

Forward Citations = 370

119 inventors:

Liming Shao (21 out of 38 patents)

Michael Charles Hewitt (21 out of 33 patents)

John Emmerson Campbell (20 out of 40 patents)

4. Harold Scott Wilkinson (17 out of 20 patents)

5. H Scott Wilkinson (17 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…